Managing hepatitis B reactivation in renal transplant recipients: A 12-year review with emphasis on early detection and early use of lamivudine

MENG-KUN TSAILai M.-Y.REY-HENG HULee C.-J.PO-HUANG LEE2020-11-192020-11-1920000041-1345https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033674951&doi=10.1016%2fS0041-1345%2800%2901500-1&partnerID=40&md5=482eba38f73d76323d8bd9aa6d130069https://scholars.lib.ntu.edu.tw/handle/123456789/521548[SDGs]SDG3lamivudine; article; clinical article; disease course; drug efficacy; early diagnosis; female; graft survival; hepatitis B; Hepatitis B virus; human; kidney transplantation; male; priority journal; Adult; Antiviral Agents; Carrier State; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Treatment OutcomeManaging hepatitis B reactivation in renal transplant recipients: A 12-year review with emphasis on early detection and early use of lamivudinejournal article10.1016/S0041-1345(00)01500-1111200082-s2.0-0033674951